Overexpression of thymosin β10 correlates with disease progression and poor prognosis in bladder cancer.

In conclusion, TMSB10 can be considered an independent factor for the poor prognosis of patients with BCa. The targeting of TMSB10 can reduce the migration and invasion of BCa cells. PMID: 31616507 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31616507?dopt=Abstract

Source: Experimental and Therapeutic Medicine - October 18, 2019 Category: General Medicine Tags: Exp Ther Med Source Type: research